Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorSaat, Nevzat
dc.contributor.authorRışvanlı, Ali
dc.contributor.authorDoğan, Halef
dc.contributor.authorŞafak, Tarık
dc.contributor.authorYılmaz, Öznur
dc.contributor.authorYüksel, Burak
dc.contributor.authorKılınç, Mehmet Akif
dc.contributor.authorTaşkın, Mustafa
dc.date.accessioned2024-08-29T06:21:38Z
dc.date.available2024-08-29T06:21:38Z
dc.date.issued2023en_US
dc.identifier.issn1124-4593
dc.identifier.urihttps://hdl.handle.net/20.500.12462/15082
dc.descriptionSaat, Nevzat (Balikesir Author)en_US
dc.description.abstractTeat canal stenosis is a significant factor that impedes milking and can lead to cows being unable to rear. Because the methods applied in the treatment of teat canal stenosis are mostly unsuccessful, animals with the disease are usually removed from breeding. In this case, it causes great damage to the livestock economy in the world. This study aimed to determine the efficacy of the veterinary argon plasma coagulation device, a newly developed treatment for teat canal stenosis. A two-stage study was conducted for this purpose. In the first stage, as a material, 30 teats from 30 cows of varying ages and breeds were selected. The cows were randomly divided into three groups. The first group (n=10) underwent closed operations using instruments such as occult mammary scalpels, papillomas, and udder probes, depending on the severity and condition of their teat stenosis. The second group (n=10) received a preparation containing 8 mg chemotrypsin, 8 mg trypsin, 4 mg papain, 100,000 IU retinol palmitate, and 120 mg tocopherol acetate per ml without any operation. The preparation, containing 4 mg chemotrypsin, 4 mg trypsin, and 10 mg papain in each ml, was administered intramammary three times at 12-hour intervals once a day at a dose of 0.4 ml/10 kg intramuscularly for three days. The third group (n=10) received veterinary argon plasma coagulation device through the teat canal. In the second stage, veterinary argon plasma coagulation device was utilized to treat 104 stenosed teat canals. Based on the findings, the group in which veterinary argon plasma coagulation device was applied exhibited the best recovery rate (90%) at the end of the third week in the study’s first phase. In the study’s second phase, 89.42% of the nipples treated with veterinary argon plasma coagulation device were completely healed. In both stages of the study, it was established that the recovery criteria could not be detected as stenosis and that the milk flow was continuous due to weekly ultrasonographic and clinical examinations. Therefore, it can be concluded that the newly developed veterinary argon plasma coagulation device is a portable device that can be used to treat teat canal stenosis.en_US
dc.description.sponsorshipNewton Fund by the Royal Academy of Engineeringen_US
dc.language.isoengen_US
dc.publisherSivar-Soc Italiana Veterinari Animali Redditoen_US
dc.rightsinfo:eu-repo/semantics/embargoedAccessen_US
dc.subjectVeterinaryen_US
dc.subjectArgonen_US
dc.subjectPlasmaen_US
dc.subjectCoagulationen_US
dc.subjectTeat Canalen_US
dc.subjectCowen_US
dc.titleEfficacy of a novel veterinary argon plasma coagulation device in treating teat canal stenosisen_US
dc.typearticleen_US
dc.relation.journalLarge Animal Reviewen_US
dc.contributor.departmentVeteriner Fakültesien_US
dc.contributor.authorID0000-0002-8135-6142en_US
dc.identifier.volume29en_US
dc.identifier.issue5en_US
dc.identifier.startpage203en_US
dc.identifier.endpage207en_US
dc.relation.tubitak"info:eu-repo/grantAgreement/TUBITAK TEYDEB-1512"
dc.relation.tubitak"info:eu-repo/grantAgreement/TUBITAK/2170002"
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster